Home | Business News | CBJ Newsmakers | Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International Conference on Alzheimer’s & Parkinson’s Diseases Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International Conference on Alzheimer’s & Parkinson’s Diseases CBJ Newsmakers RecommendedNexus REIT Waives Purchase Conditions to Acquire $44.8MM of Industrial PropertiesCN Proposal Deemed Superior by Kansas City SouthernUnigold Updates Mineral Resource Estimate for the Candelones Project
